Protein discovery reveals potential treatment target for common fatty liver disease

Дата публикации: 19-10-2026 21:40:08

The mechanisms that cause the world's most common chronic liver disease—metabolic dysfunction-associated steatotic liver disease (MASLD)—to develop and progress are still not fully understood.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Mouse study identifies bile acid pathways that may reduce liver fat	0	9.19	17-09-2026
2	Researchers identify high-IgA MASLD subtype linked to liver-related events	0	11.32	09-10-2026
3	Serum C7 levels predict liver-related events in metabolic fatty liver disease, study finds	0	9.85	08-10-2026
4	GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease	0	6.87	13-10-2026
5	Why some adults under 50 may develop early-onset cirrhosis from fatty liver disease	0	13.37	16-09-2026
6	‘BMI does not tell the whole story in MASLD’; body roundness might	0	8.97	16-10-2026
7	Drug candidate treats severe fatty liver disease by protecting the gut in animal models	2	7	07-07-2026
8	Appetite-suppressing hormone may protect liver from inflammation through newly discovered signaling pathway	0	7.49	10-08-2026
9	Experimental drug reverses severe fatty liver disease by repairing the gut	0	5	11-07-2026
10	Descubren el mecanismo del hígado para regular la glucosa en el ayuno y combatir la diabetes y obesidad	5	8	24-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.8. Источник: medicalxpress.com.